Laman UtamaOCEA • NASDAQ
add
Ocean Biomedical Inc
Tutup sebelumnya
$0.044
Julat hari
$0.042 - $0.047
Julat tahun
$0.039 - $2.17
Permodalan pasaran
8.41J USD
Bilangan Purata
50.05J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 1.75J | 365.61% |
Pendapatan bersih | 283.00K | 101.68% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | — | — |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | — | — |
Jumlah aset | 902.00K | -83.60% |
Jumlah liabiliti | 98.52J | 2.34% |
Jumlah ekuiti | -97.62J | — |
Syer tertunggak | 166.01J | — |
Harga kepada buku | -0.02 | — |
Pulangan pada aset | -430.92% | — |
Pulangan pada modal | 5.65% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Dis 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 283.00K | 101.68% |
Tunai daripada operasi | -2.52J | -190.99% |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | 2.50J | 198.45% |
Perubahan bersih dalam tunai | -16.00K | 40.74% |
Aliran tunai bebas | -4.49J | -247.31% |
Perihal
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Diasaskan
2019
Ibu pejabat
Tapak web
Pekerja
7